We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Bacteria-Repelling Silver Coating Prevents Infection of Implantable Medical Devices

By HospiMedica International staff writers
Posted on 28 Apr 2022
Print article
Image: Photo of a coated versus an uncoated catheter (Photo courtesy of UBC)
Image: Photo of a coated versus an uncoated catheter (Photo courtesy of UBC)

Implanted medical devices can save lives, but they carry a great risk of infection which usually arises from contamination as the device is being implanted. Urinary tract infections from catheters, for example, are among the most common hospital-acquired infections. Silver has long been viewed as a potential solution because of its ability to kill bacteria, but its use on implanted devices poses several challenges that have stumped researchers until now. The main challenge is its toxicity. Too much of the poison that kills bacteria can also be bad for human cells and tissues. Coatings incorporating silver have also proven overly complicated to make, lacked durability, became easily gummed up with proteins or crystals, or simply didn’t adhere well to the surface of devices and implants. In order to overcome these complications of silver that have challenged scientists for years, researchers screened dozens of chemical components to develop a silver-based coating that can easily be applied to devices such as catheters and stents.

The novel formulation developed by researchers at University of British Columbia (UBC, Vancouver, BC, Canada) is being seen as a ‘silver bullet’ to kill bacteria and keep them from infecting patients who have medical devices implanted. In order to generate the coating, the researchers combined silver nitrate, dopamine and two hydrophilic polymers. Once implanted, it releases silver ions gradually in small, controlled quantities - enough to kill bacteria but not harm human cells. It repels live and dead bacteria and other fouling agents from its surface, keeping it clean. It also maintains its killing activity for longer than has been achieved by other coatings.

The coating could be applied to almost any material without pre-treatment used to make medical devices such as central venous catheters, urethral catheters, peritoneal catheters, feeding tubes, vascular grafts, urethral stents or orthopedic implants. Silver is a precious metal, but the amount required is so small that it would add only about 50 cents to the cost of a catheter. The researchers tested it for 30 days in an environment with a high concentration of diverse and resilient bacteria known to cause infections. Their device came away with no bacteria attached. In a seven-day test with live rats, it performed the same way and did not harm the rats’ tissues. The research team looks forward to seeing how the coating performs in clinical trials, and is optimistic that their discovery could be in wide use to prevent infections in patients within the next decade.

“This is a highly effective coating that won’t harm human tissues and could potentially eliminate implant-associated infections. It could be very cost-effective and could also be applicable to many different products,” said Dr. Jayachandran Kizhakkedathu, professor in UBC’s department of pathology and laboratory medicine, Centre for Blood Research and Life Sciences Institute and co-senior author of the study.

“Other silver-based coatings rely on contact killing, meaning the bacteria have to attach to the material in order to be exposed to the silver and die. This results in dead bacteria building up on the surface over time and rendering the device ineffective,” explained the study’s other co-senior author Dr. Dirk Lange, associate professor in UBC’s department of urologic sciences and director of basic science research at the Stone Centre at Vancouver General Hospital. “We’re preventing that by keeping bacteria off the surface in the first place, and then killing them with the release of silver. Since we prevent attachment of both live and dead bacteria, this coating has significant potential to maintain a clean surface for any device or material for an extended period of time, which is something we haven’t seen so far.”

Related Links:
University of British Columbia 

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Endoscope Tracking Software
T-DOC Endo

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.